| ||||||||||||||||||||
The following supplementary figure and tables accompany the Article by van den Akker-van Marle et al., J Natl Cancer Inst 2002;94:193-204.
Supplementary Figure 1. Schematic representation of the disease model for cervical cancer illustrating preclinical stages and screen-detected stages.
Supplementary Table 1. Screening policies evaluated in the cost-effectiveness analysis.
Supplementary Table 2. Input parameter: distribution of the total incidence of progressive and regressive preinvasive cervical neoplasia by age group.
Supplementary Table 3. Input parameter: probability of long-term survival after a clinical diagnosis of cervical cancer stage IB or II+ by age group.
Supplementary Table 4. Input parameter: costs of screening, diagnosis, treatment, and palliative care for cervical cancer.
| ||||||||||||||||||||